Cargando…
Salvage Treatment for Invasive Aspergillosis and Mucormycosis: Challenges, Recommendations and Future Considerations
Invasive mold diseases are devastating systemic infections which demand meticulous care in selection, dosing, and therapy monitoring of antifungal drugs. Various circumstances regarding PK/PD properties of the applied drug, resistance/tolerance of the causative pathogen or host intolerability can le...
Autores principales: | Egger, Matthias, Bellmann, Romuald, Krause, Robert, Boyer, Johannes, Jakšić, Daniela, Hoenigl, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106327/ https://www.ncbi.nlm.nih.gov/pubmed/37077251 http://dx.doi.org/10.2147/IDR.S372546 |
Ejemplares similares
-
Treatment of Invasive Aspergillosis: How It’s Going, Where It’s Heading
por: Boyer, Johannes, et al.
Publicado: (2023) -
Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
por: Jenks, Jeffrey D, et al.
Publicado: (2018) -
Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two‐centre mixed cohort study
por: Hoenigl, Martin, et al.
Publicado: (2021) -
Utility of Serum 1,3-β-d-Glucan Testing for Diagnosis and Prognostication in COVID-19-Associated Pulmonary Aspergillosis
por: Egger, Matthias, et al.
Publicado: (2022) -
Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis
por: Hoenigl, Martin, et al.
Publicado: (2023)